key: cord-0252743-8w5h530j
authors: nan
title: Lethal exacerbation of Pneumocystis carinii pneumonia in severe combined immunodeficiency mice after infection by pneumonia virus of mice
date: 1993-04-01
journal: J Exp Med
DOI: nan
sha: 24f98f785d877c6f05bb2957428e187d6f91a2f6
doc_id: 252743
cord_uid: 8w5h530j

Mice homozygous for the mutant allele scid (severe combined immunodeficiency) have been described as excellent models for Pneumocystis carinii (Pc) pneumonia (PCP), a major health problem in patients with acquired immune deficiency syndrome (AIDS) and other immunodeficiency states. Other microorganisms have been shown to infect AIDS patients simultaneously with Pc, but whether one opportunist is able to directly influence the pathogenicity of another has not been determined previously. We have deliberately coinfected scid mice (with extent Pc infection) with a variety of primarily pneumotropic viruses and bacteria and have identified pneumonia virus of mice as causing a dramatic increase in the density of Pc organisms and the morbidity due to PCP in immunodeficient scid mice. This finding has clinical significance in the management of PCP, in that the identification and treatment of coinfecting pneumotropic pathogens may be as important as treatment targeted at Pc. A search for other synergistic (or antagonistic) microorganisms and determination of their mechanism(s) of action in altering the progression of PCP is indicated.

Mice homozygous for the mutant allele scid (severe combined immunodeficiency) have been described as excellent models for Pneumocystis carinii (Pc) pneumonia (PCP), a major health problem in patients with acquired immune deficiency syndrome (AIDS) and other immunodeficiency states.

Other microorganisms have been shown to infect AIDS patients simultaneously with Pc, but whether one opportunist is able to directly influence the pathogenicity of another has not been determined previously. We have deliberately coinfected scid mice (with extant Pc infection) with a variety of primarily pneumotropic viruses and bacteria and have identified pneumonia virus of mice as causing a dramatic increase in the density of Pc organisms and the morbidity due to PCP in immunodeficient scid mice. This finding has clinical significance in the management of PCP, in that the identification and treatment of coinfecting pneumotropic pathogens may be as important as treatment targeted at Pc. A search for other synergistic (or antagonistic) microorganisms and determination of their mechanism(s) of action in altering the progression of PCP is indicated. p atients with AIDS commonly develop and die from opportunistic infections (1) . The spectrum of infectious diseases seen in AIDS patients includes those caused by viruses, bacteria, fungi, and protozoa (2) . Chief among these pathogens is the fungus (3, 4) Pneumocystis carinii (Pc) , with an incidence of '~80% in AIDS patients (5) . Mixed infections involving Pc have been described in both AIDS (Pc plus CMV, Mycobacteriura spp. or Legionella pneumophila) [2, 6] ) and in malnourished children (where coinfecting organisms include Toxoplasma gondii, Cryptosporidium, Candida sp., Cryptococcus neoformans, Mycobacterium sp., Chlamydia trachomatis, CMV, herpes simplex, herpes zoster, EBV, and respiratory syncytial virus [KSV]) (7) . Whether the presence of a specific coinfectious organism is neutral, antagonistic, or synergistic in interaction with Pc has been largely unaddressed. However, one retrospective study of patients with HIV-related pneumonia concluded that coinfection by CMV (the most commonly isolated viral copathogen in AIDS) did not adversely affect the prognosis of patients with Pneumocystis carinii pneumonia (PCP) (6) .

In our original studies on PCP in scid mice (8) , the longevity ofscid mice reared in a barrier facility was greater than that of mice reared in a conventional room, although PCP was the principle cause of morbidity in both environments. Among 14 species of bacteria, mycoplasma, and viruses checked, the only identified difference in pneumotropic microorganisms between the two rooms was the persistent finding of Pasteurella pneumotropica (Pp) in the conventional room, although pneumotropic viruses such as pneumonia virus of mice (PVM) had historically also been found on rare occasions. We thus initiated experiments involving the deliberate challenge of Pc-infected scid mice with various microorganisms with tropisms primarily or secondarily directed toward tissues of the respiratory tract to determine whether such coinfection would exacerbate PCP.

Mice. Immunodeficient mutant scid/scid (hereafter termed scic 0 mice were obtained originally from the Institute for Cancer Research (Philadelphia, PA) on inbred strain background C.B-17/Icr.

The scid mutation was transferred by us to several standard inbred strains by greater that 10 backcrosses, and the congenic strains BALB/cBy-scid and C3H/HeSn-sc/d were then propagated by brother x sister matings. All scid mice maintained in our colony develop spontaneous PCP and die at median ages of 20 wk (BALB-scid) and 24 wk (C3H-scid). Additional details on the genetics, natural history, and pathology of PCP in scid mice have been described (8) .

Homozygous scid and congenic +/+ mice for these experiments were inoculated with specific microorganisms and thereafter maintained in polycarbonate cages with filter tops until necropsy. All cage changes and experimental procedures were performed in a biological safety cabinet, and all cages, bedding, feed, and water were autoclaved. The number of mice studied in each experiment is indicated as the denominator (number at risk) in the morbidity data presented (see Fig. 1 and Table 1 ).

Bouin's solution, embedded in para~n, sectioned at 5/~M, and stained with hematoxylin and eosin (H&E) or Grocott's methenamine silver (GMS) and light green (I, (3) . Tissue sections were evaluated for the presence and intensity of PCP-related histopathology and cyst levels as described previously (8) .

Immunohistochemistry. PVM andPc were identified on serial sections of infected scid lung by capillary gap technology using a robotic immunohistochemistry workstation (9) (Code-On; Fisher Scientific, Pittsburgh, PA). Paraffin sections to be stained for PVM were predigested for 30 min in a solution of 0.25% crude pancreatic type II trypsin (Sigma Immunochemicals, St. Louis, MO) in 0.02% CaC12, followed by overnight incubation with polyclonal rat anti-PVM antiserum. Sections were then incubated for 30 rain with biotinylated goat anti-rat Ig, then streptavidinhorseradish peroxidase (SA-HPO; Southern Biotechnology Associates, Birmingham, AL), and finally with chromagen 3-amino, 9-ethylcarbazole (AEC; Biomeda, Foster City, CA). Pc was revealed (without trypsinization) on adjacent serial sections by 30-rain incubations with polyclonal mouse anti-Pc (10), biotinylated goat anti-mouse Ig r, and finally SA-HPO and AEC as above. Stained slides were viewed and representative fields were digitized using an Olympus research microscope equipped with a Sony DXC-930 CCD color video camera and a Macintosh Ilci computer with a Scion LG-3 8-bit grayscale frame grabber (Scion Corp., Frederick, MD). Acquisition and initial manipulation of the images were done using the public domain National Institutes of Health (NIH) Image 1.47 program written by W. Rasband (available by anonymous Interuet FTP from ziplv.nimh.nih.gov ). The superimposed images of PVM-and Pc-stained tissue (from adjacent serial sections of a dually infected scid lung; see Microorganisms and Inoculation Procedures. The following microorganisms were investigated to determine their ability to alter the course of PCP in scid mice. Recipient mice were 6-10-wk-old at time of inoculation. Unless otherwise stated, C3H mice were used in these experiments because of the relative hardiness and breeding success of C3H-scid mice among various congenic scid stocks in our colony.

PVM. 200 fluorescent focus units (FFU, see below) of PVM were inoculated intranasally (11) into C3H-scid and +/+ mice. The PVM inoculum was a pooled lung homogenate from naturally infected athymic mice (12) that was isolated and quantified in BHK 21 cell cultures as previously described (11) .

terization of strain MHV-Y was described by Barthold Pp Cultures. Groups of mice were necropsied at 1, 2, and 3 mo after intranasal inoculation. Nasopharyngeal washes were obtained and plated on blood agar media, and growth was documented after 24 h of culture.

Statistics. Results were expressed as the arithmetic mean _+ SE of the mean. Two-tailed Student's t tests (for comparison of unpaired samples) were performed, and p values ~<0.05 were considered to be significant.

Synergistic Effect of PVM on PCP. All 26 C3H-scid mice inoculated with PVM died or were necropsied when morbidly ill 25-28 d after infection (dpi) (Fig. 1 A) . No morbidity was exhibited by any of the noninoculated scid mice or by treated or untreated C3H-+/+ mice. Histological examination revealed that morbidity was associated with pulmonary pathology typical of PCP (8) . Characteristic alveolifilling foamy matrix comprised primarily of Pc organisms, activated macrophages, remnants of phagocytic cells, and proteinaceous exudate was found to be extensive in distribution and density. Thickening of alveolar interstitium was also pronounced. The extent of pulmonary pathology (Fig. 1 B) was significantly greater in PVM-treated scid mice than in their noninoculated counterparts. Neither PVM-treated nor untreated C3H-+/+ mice had significant pulmonary pathology, although some of the PVM-treated +/+ mice did exhibit occasional intraalveolar inflammatory cells, minor focal hyperemia, and hemorrhage characteristic of PVM infection (12, 17) . Mutant scid mice inoculated with PVM had nearly five times greater density of Pc cysts than noninoculated control scid mice (Fig. 1 C) . As expected, no Pc cysts were observed in either PVM-inoculated or noninoculated C3H-+/+ mice.

To test the ef~cacy of viral inoculation, lungs were removed at necropsy (25-28 dpi) and PVM virus was titrated. Virus recoveries <2.5 logl0 FFU per gram of lung were considered negative. 13 of 14 (93%) inoculated scid mice were positive ( Fig. 1 D) , whereas none of the noninoculated scid mice or the inoculated +/+ mice was positive, indicating that: (a) scid mice were free of PVM before experimental infection; and (b) wild-type mice, but not the immunodeficient scid mice, were able to clear PVM. Viral serology was also conducted. All of 22 inoculated +/+ mice were seropositive whereas none of 14 noninoculated +/+ mice and none of 14 inocu-lated scid mice was positive. These data document lack of prior infection and successful intranasal inoculation. Overall, these findings demonstrate that PVM directly increases infection and morbidity by Pc organisms. As demonstrated by microscopy and image analysis, PVM and Pc in dually infected scid lungs were distributed independently of each other at the microanatomical level. PMV was detected primarily within the cytoplasm of alveolar and bronchiolar epithelial cells, whereas Pc was found extracellularly but in close proximity to the alveolar epithelial lining. Clusters of Pc and PVM-containing cells were diffusely scattered throughout the pulmonary parenchyma but in general did not colocalize (Fig. 2) . PVM could not be detected in the lungs of scid mice that were not deliberately infected.

Microorganisms Not Producing a Synergistic Effect on PCP. Four other pneumotropic microorganisms besides PVM were evaluated for possible synergism with Pc. There was no evidence of exacerbation of PCP in any of the following dually infected scid mice (Table 1) .

MHV-Y. Morbidity signs were exhibited by all 25 inoculated C3H-scid mice allowed to age and survival ranged from 31 to 59 dpi. This morbidity was not related to heightened presence of Pc organisms as both cyst density (Table 1) and histopathology associated with PCP (data not shown) were similar among infected and noninfected scid mice. Only one of four noninfected scid mice became moribund (at 34 dpi); the remaining thrifty mice were necropsied at 45 dpi. Serological tests of C3H-+/+ mice confirmed the success of intranasal MHV-Y infection. As expected, scid mice failed to generate detectable antibody.

RSV. RSV did not significantly exacerbate Pc cyst density, pathogenicity, or morbidity from Pc in BALB/c-scid mice. 6 out of 16 RSV-inoculated and 2 out of 4 noninoculated scid mice became ill and were necropsied between 33 and 55 dpi. Serological tests of BALB/c-+/+ mice confirmed the success of the RSV inoculation.

SV. All 20 scid and eight +/+ mice inoculated with SV became morbidly ill by 12 dpi; all noninoculated control mice remained thrifty and were necropsied in parallel The 19 scid mice tested had recoverable SV 7-12 dpi with titers 5.1-5.5 log10 FFU. Two of the inoculated +/+ mice were virus positive (4.8 _+ 0.8 log10 FFU) at 7 dpi; one +/+ assayed at 12 dpi was virus negative. There was no significant difference in the density of Pc cysts (Table 1 ) or in PCP-associated pulmonary histopathology (data not shown) between SVinfected and uninfected scid mice. Because of the rapidity of disease development after this dose of SV, there may have been insu~cient time to alter the pathogenesis of PCP.

Pp. By 30 dpi, 4 of 24 Pp-inoculated scid mice, but none ofll noninoculatedscidand none of 8 inoculated +/+ mice, had died. This slightly enhanced morbidity was not associated with increased presence of Pc (Table 1 ) or characteristic PCP histopathology (data not shown). Pp was cultivated from nasopharyngeal washes from one of nine uninoculated and approximately three fourths of inoculated scid mice (X 2 =6.69; p <.01). Although not exacerbating PCP, the increased morbidity found in Pp-inoculated scid mice may par- tially explain the reduced longevity of scid mice in the conventional versus barrier facilities described in the introduction.

The findings presented here constitute the first evidence of a fatal synergism between a coinfective pneumotropic microorganism and Pc. PVM, alone among the microorganisms tested, caused an increase in the density of Pc organisms, an increase in the severity of histopathologically defined PCP, and earlier morbidity than those ofscid mice not coinfected. The uniqueness of PVM's influence is suggested by the observations that MHV-Y, SV, and Pp were infective and caused morbidity but did not increase the density of Pc or augment the severity of PCP. Coinfection with human RSV was not detrimental to scid mice. That scid mice (deficient in both ceU-mediated and humoral immunity) were readily infected with PVM (considered an apathogenic virus) is not surprising based on earlier studies of the respiratory disease produced in T cell-deficient nude (nu) mice singularly challenged with PVM (12) . In contrast with this fatal synergism of PVM and Pc, Pesanti (18) described a protective effect of preexisting Pseudomonas pneumonitis on the development of glucocorticoid-induced PCP.

Some histopathological hallmarks of both PVM and Pc in-fection are similar (interstitial pneumonitis with a preponderance of macrophages), yet each has unique characteristics. PVM infection of an immunocompromised host has marked intraalveolar hemorrhage and substantial fibrin deposition, whereas PCP typically has an extensive intraalveolar accumulation of trophozoite-rich foamy matrix. It should be emphasized that all dually infected scid mice necropsied had typical PCP pathology. The hallmarks of PVM infection were seen only in diminished form in less than a quarter of the cases. At present, we can only speculate regarding the possible mechanisms underlying the synergism of PVM and Pc. We demonstrated that PVM and Pc were diffusely scattered throughout the lung parenchyma, but only infrequently colocalized. Thus, a contact-dependent effect of PVM on enhancing the proliferation of Pc organisms seems unlikely. The possibility that PVM could sufficiently alter the biochemical microenvironment (pH, metabolic factors, etc.) to the benefit of Pc should be considered. Alternatively, PVM may detrimentally affect the number or function of alveolar macrophages, the principle means of controlling Pc organisms in scid mice. Since macrophages are dominant in the inflammatory responses to both Pc and FVM, infection by PVM may saturate the capacity for production, immigration, or activation of these phagocytes, resulting in increased numbers of Pc. Also, as morbidity in PCP seems to be related to pulmonary (c).

insufficiency associated with both thickening of the alveolar septa as well as dense alveolar obstruction (organisms, desquamated epithelia, and active and remnant phagocytic cells), any factor causing additional recruitment, proliferation, and activation of macrophages may be detrimental to the host. In support of this scenario, we have previously shown that scid mice have heightened morbidity due to the hyperresponsiveness of macrophages after the transfer of immunocompetent Pc-sensitized CD4 + T cells (10) . Finally, the nonspecific host response to PVM may lead to an altered balance of cytokines critical to the anti-Pc response. For example, TNF-o~ produced by alveolar macrophages has been reported to play a major role in the control of PCP in AIDS patients (19) . Human (and bovine) RSV (HRSV) and PVM are classified by morphological criteria as unique members of the genus Pneumovirus (20) but are reported to either share (21) or not share (22) antigenic surface determinants. Recent molecular studies have shown weak homology between proteins coded by genes 1 and 2 of PVM and analogous genes 1C and 1B of HKSV (23) . Thus, the fatal synergism of PVM and Pc described here may or may not be predictive of similar consequences in HRSV-Pc dual infections in immunodeficient (e.g., AIDS) patients.

In summary, these results support the broad notion that coinfection by secondary microorganisms may have significant clinical relevance in terms of diagnosis, prognosis, and therapy of primary (e.g., Pc) opportunistic infection. Further, this experimental model may be exploitable for determining the fundamental mechanism(s) and effective therapies for such detrimental synergy.

Autopsy pathology in the acquired immune deficiency syndrome

Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi

Pneumocystis carinii: sequence from ribosomal RNA implies a close relationship with fungi

Pneumocystis carinii pneumonia: therapy and prophylaxis

Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome

Pneumonia associated with infection with pneumocystis, respiratory syncytial virus, chlamydia, mycoplasma, and cytomegalovirus in children in Papua New Guinea

Spontaneous Pneurnocystis carinii pneumonia in immunodeficient mutant scid mice. Natural history and pathobiology

Immunocytochemistry is automated: development of a robotic workstation based upon the capillary action principle

Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4 § but not CD8 § T cells into severe combined immunodeficiency mice

Response of weanling random-bred mice to infection with pneumonia virus of mice (PVM)

Respiratory disease and wasting in athymic mice infected with pneumonia virus of mice

Epizootic coronaviral typhlocolitis in suckling mice

Respiratory syncytial virus infection in inbred mice

Sendai virus infection in genetically resistant and susceptible mice

Serologic tests for detection of antibody to rodent viruses

An immunofluorescence test for detection of serum antibody to rodent coronaviruses

Effects of bacterial pneumonitis on development of pneumocystosis in rats

Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneurnocystis carinii pneumonia

Fatal pneumonia with terminal emaciation in nude mice caused by pneumonia virus of mice

Polypeptides of pneumonia virus of mice. I. Immunological cross-reactions and posttranslational modifications

A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus

Genes 1 and 2 of pneumonia virus of mice encode proteins which have little homology with the 1C and 1B proteins of human respiratory synctial virus